Saniona is active in biotechnology. Today, research and development of drugs for the treatment of nerve diseases and other autoimmune diseases are conducted. The drug portfolio is broad and includes drugs that are currently in various clinical phases. Some of the work is also carried out in collaboration with other cooperation partners in the pharmaceutical industry. Saniona is headquartered in Glostrup.
Suurimmat omistajatLähde: Millistream Market Data AB
|Nordnet Pensionsförsäkring AB